Prevacid 24 Hrlansoprazole

According to the FDA label: Lansoprazole delayed-release capsules are a proton pump inhibitor (PPI) indicated for the: Treatment of active duodenal ulcer in adults ( 1.1 ) Eradication of H.

121,431 adverse event reports submitted to the FDA (2003–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Prevacid 24 Hr in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Prevacid 24 Hr adverse event reports by reporter sex
SexReports
Female57,587
Male46,812
Unknown256

By Age Group

View age group data as a table
Prevacid 24 Hr adverse event reports by reporter age group
Age groupReports
0-173,251
18-343,806
35-4910,866
50-6421,746
65-7421,234
75+24,390

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Prevacid 24 Hr. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Prevacid 24 Hr adverse event reports by reported outcome
OutcomeReports
Other Serious76,518
Hospitalization50,657
Death14,897
Life-Threatening10,743
Non-Serious8,948
Disability7,986

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Prevacid 24 Hr. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Prevacid 24 Hr adverse event reports by year
YearReports
20031
20041,299
20051,406
20061,113
20071,294
20081,659
20091,691
20101,934
20112,729
20123,422
20132,970
20143,516
20154,952
20166,294
20175,663
201815,384
201917,277
20208,896
20217,875
20227,149
20237,644
20248,161
20257,399
2026 (partial)1,703

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Prevacid 24 Hr

In FDA adverse event reports that mention Prevacid 24 Hr, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026